Report cover image

Global Sitagliptin Metformin Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 180 Pages
SKU # APRC20276998

Description

Summary

According to APO Research, The global Sitagliptin Metformin Extended Release Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sitagliptin Metformin Extended Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sitagliptin Metformin Extended Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Sitagliptin Metformin Extended Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sitagliptin Metformin Extended Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sitagliptin Metformin Extended Release Tablets include Chia Tai Tianqing Pharmaceutical Group, Jiangsu Xuantai Pharmaceutical Co., Ltd., Jiangsu Anbisheng Pharmaceutical Co., Ltd., Sandoz Pty Ltd, Merck & Co., Inc. and Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sitagliptin Metformin Extended Release Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sitagliptin Metformin Extended Release Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Sitagliptin Metformin Extended Release Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sitagliptin Metformin Extended Release Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sitagliptin Metformin Extended Release Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sitagliptin Metformin Extended Release Tablets sales, projected growth trends, production technology, application and end-user industry.

Sitagliptin Metformin Extended Release Tablets Segment by Company

Chia Tai Tianqing Pharmaceutical Group
Jiangsu Xuantai Pharmaceutical Co., Ltd.
Jiangsu Anbisheng Pharmaceutical Co., Ltd.
Sandoz Pty Ltd
Merck & Co., Inc.
Abbott
Sitagliptin Metformin Extended Release Tablets Segment by Type

Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
Sitagliptin Metformin Extended Release Tablets Segment by Application

Hospital
Clinic
Other
Sitagliptin Metformin Extended Release Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin Metformin Extended Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin Metformin Extended Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin Metformin Extended Release Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sitagliptin Metformin Extended Release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sitagliptin Metformin Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sitagliptin Metformin Extended Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sitagliptin Metformin Extended Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

180 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Sitagliptin Metformin Extended Release Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Sitagliptin Metformin Extended Release Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Sitagliptin Metformin Extended Release Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Sitagliptin Metformin Extended Release Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Sitagliptin Metformin Extended Release Tablets Market Dynamics
2.1 Sitagliptin Metformin Extended Release Tablets Industry Trends
2.2 Sitagliptin Metformin Extended Release Tablets Industry Drivers
2.3 Sitagliptin Metformin Extended Release Tablets Industry Opportunities and Challenges
2.4 Sitagliptin Metformin Extended Release Tablets Industry Restraints
3 Sitagliptin Metformin Extended Release Tablets Market by Manufacturers
3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Manufacturers (2020-2025)
3.3 Global Sitagliptin Metformin Extended Release Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Sitagliptin Metformin Extended Release Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Sitagliptin Metformin Extended Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Sitagliptin Metformin Extended Release Tablets Manufacturers, Product Type & Application
3.7 Global Sitagliptin Metformin Extended Release Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sitagliptin Metformin Extended Release Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Sitagliptin Metformin Extended Release Tablets Tier 1, Tier 2, and Tier 3
4 Sitagliptin Metformin Extended Release Tablets Market by Type
4.1 Sitagliptin Metformin Extended Release Tablets Type Introduction
4.1.1 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
4.1.2 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
4.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type
4.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2020-2031)
4.2.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2020-2031)
4.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type
4.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2020-2031)
4.3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2020-2031)
5 Sitagliptin Metformin Extended Release Tablets Market by Application
5.1 Sitagliptin Metformin Extended Release Tablets Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application
5.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2020-2031)
5.2.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2020-2031)
5.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application
5.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2020-2031)
5.3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2020-2031)
6 Global Sitagliptin Metformin Extended Release Tablets Sales by Region
6.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region (2020-2031)
6.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region (2020-2025)
6.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region
7.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region
7.1.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2020-2025)
7.1.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2026-2031)
7.1.4 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Sitagliptin Metformin Extended Release Tablets Revenue (2020-2031)
7.2.2 North America Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Sitagliptin Metformin Extended Release Tablets Revenue (2020-2031)
7.3.2 Europe Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Chia Tai Tianqing Pharmaceutical Group
8.1.1 Chia Tai Tianqing Pharmaceutical Group Comapny Information
8.1.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
8.1.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.1.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
8.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
8.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Comapny Information
8.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Business Overview
8.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments
8.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
8.3.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Comapny Information
8.3.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Business Overview
8.3.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.3.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments
8.4 Sandoz Pty Ltd
8.4.1 Sandoz Pty Ltd Comapny Information
8.4.2 Sandoz Pty Ltd Business Overview
8.4.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.4.5 Sandoz Pty Ltd Recent Developments
8.5 Merck & Co., Inc.
8.5.1 Merck & Co., Inc. Comapny Information
8.5.2 Merck & Co., Inc. Business Overview
8.5.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.5.5 Merck & Co., Inc. Recent Developments
8.6 Abbott
8.6.1 Abbott Comapny Information
8.6.2 Abbott Business Overview
8.6.3 Abbott Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio
8.6.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Sitagliptin Metformin Extended Release Tablets Value Chain Analysis
9.1.1 Sitagliptin Metformin Extended Release Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Sitagliptin Metformin Extended Release Tablets Production Mode & Process
9.2 Sitagliptin Metformin Extended Release Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Sitagliptin Metformin Extended Release Tablets Distributors
9.2.3 Sitagliptin Metformin Extended Release Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.